{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:22:49Z","timestamp":1791595369626,"version":"4.3.4"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG27613"],"award-info":[{"award-number":["IG27613"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN20227YR8AW"],"award-info":[{"award-number":["PRIN20227YR8AW"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 332,project A4"],"award-info":[{"award-number":["TRR 332,project A4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["BM1404\/CA20117"],"award-info":[{"award-number":["BM1404\/CA20117"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) represent the most investigated type of \u201cimmunosuppressive\u201d neutrophils in humans. However, a detailed understanding of human PMN-MDSCs has been hindered for years by limited knowledge of their specific markers for sorting and purification, as well as by their very low numbers in patient circulation. Recently, the use of advanced technologies has shown that human PMN-MDSCs are generated during emergency granulopoiesis and comprise a heterogeneous population of both immature and mature neutrophils. It has also been shown that human\u00a0mature PMN-MDSCs\u00a0(\n                    <jats:bold>m<\/jats:bold>\n                    PMN-MDSCs) perform immunosuppressive functions through transcriptional reprogramming during maturation. Furthermore, single-cell RNA sequencing experiments have shown that human\n                    <jats:bold>m<\/jats:bold>\n                    PMN-MDSCs and tumor-associated neutrophils (TANs) share transcriptomic similarities, therefore uncovering a potential relationship between them. In this Perspective, we discuss: i) how our knowledge on human PMN-MDSCs has advanced; ii) the criteria for discriminating human PMN-MDSCs from normal neutrophils or other immunosuppressive neutrophil populations; iii) recent findings revealing that\u00a0human mPMN-MDSCs exhibit transcriptomic features suggestive of functions beyond immunosuppression.\n                  <\/jats:p>","DOI":"10.1038\/s44318-026-00829-6","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:56:37Z","timestamp":1780682197000},"page":"5193-5206","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human immunosuppressive neutrophils: recent answers to old and new questions"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5342-1162","authenticated-orcid":false,"given":"Patrizia","family":"Scapini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8988-8187","authenticated-orcid":false,"given":"Chiara","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Brandau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-1806","authenticated-orcid":false,"given":"Marco A","family":"Cassatella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"829_CR1","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1182\/bloodadvances.2019031609","volume":"3","author":"CEM Aarts","year":"2019","unstructured":"Aarts CEM, Hiemstra IH, Beguin EP, Hoogendijk AJ, Bouchmal S, van Houdt M, Tool ATJ, Mul E, Jansen MH, Janssen H et al (2019) Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair. Blood Adv 3:3562\u20133574","journal-title":"Blood Adv"},{"key":"829_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12989","volume":"48","author":"CEM Aarts","year":"2018","unstructured":"Aarts CEM, Kuijpers TW (2018) Neutrophils as myeloid-derived suppressor cells. Eur J Clin Invest 48:e12989","journal-title":"Eur J Clin Invest"},{"key":"829_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/bjh.19656","volume":"205","author":"K Aliazis","year":"2024","unstructured":"Aliazis K, Yenyuwadee S, Phikulsod P, Boussiotis VA (2024) Emergency myelopoiesis in solid cancers. Br J Haematol 205:798\u2013811","journal-title":"Br J Haematol"},{"key":"829_CR4","doi-asserted-by":"publisher","first-page":"e1344804","DOI":"10.1080\/2162402X.2017.1344804","volume":"6","author":"AA Al-Khami","year":"2017","unstructured":"Al-Khami AA, Zheng L, Del Valle L, Hossain F, Wyczechowska D, Zabaleta J, Sanchez MD, Dean MJ, Rodriguez PC, Ochoa AC (2017) Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells. Oncoimmunology 6:e1344804","journal-title":"Oncoimmunology"},{"key":"829_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/imr.13176","volume":"314","author":"BB Antuamwine","year":"2023","unstructured":"Antuamwine BB, Bosnjakovic R, Hofmann-Vega F, Wang X, Theodosiou T, Iliopoulos I, Brandau S (2023) N1 versus N2 and PMN-MDSC: a critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol Rev 314:250\u2013279","journal-title":"Immunol Rev"},{"key":"829_CR6","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1073\/pnas.1722056115","volume":"115","author":"E Bandala-Sanchez","year":"2018","unstructured":"Bandala-Sanchez E, NGB, Goddard-Borger ED, Ngui K, Naselli G, Stone NL, Neale AM, Pearce LA, Wardak A, Czabotar P et al (2018) CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function. Proc Natl Acad Sci USA 115:7783\u20137788","journal-title":"Proc Natl Acad Sci USA"},{"key":"829_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fonc.2020.00109","volume":"10","author":"C Bergenfelz","year":"2020","unstructured":"Bergenfelz C, Leandersson K (2020) The generation and identity of human myeloid-derived suppressor cells. Front Oncol 10:109","journal-title":"Front Oncol"},{"key":"829_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.672520","volume":"12","author":"C Blanco-Camarillo","year":"2021","unstructured":"Blanco-Camarillo C, Aleman OR, Rosales C (2021) Low-Density Neutrophils in Healthy Individuals Display a Mature Primed Phenotype. Front Immunol 12:672520","journal-title":"Front Immunol"},{"key":"829_CR9","doi-asserted-by":"publisher","first-page":"e1003993","DOI":"10.1371\/journal.ppat.1003993","volume":"10","author":"NL Bowers","year":"2014","unstructured":"Bowers NL, Helton ES, Huijbregts RP, Goepfert PA, Heath SL, Hel Z (2014) Immune suppression by neutrophils in HIV-1 infection: role of PD-L1\/PD-1 pathway. PLoS Pathog 10:e1003993","journal-title":"PLoS Pathog"},{"key":"829_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1189\/jlb.0310162","volume":"89","author":"S Brandau","year":"2011","unstructured":"Brandau S, Trellakis S, Bruderek K, Schmaltz D, Steller G, Elian M, Suttmann H, Schenck M, Welling J, Zabel P et al (2011) Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J Leukoc Biol 89:311\u2013317","journal-title":"J Leukoc Biol"},{"key":"829_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00262-018-2170-8","volume":"68","author":"AM Bruger","year":"2019","unstructured":"Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA et al (2019) How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Cancer Immunol Immunother 68:631\u2013644","journal-title":"Cancer Immunol Immunother"},{"key":"829_CR12","first-page":"843","volume":"68","author":"JA Bryk","year":"2010","unstructured":"Bryk JA, Popovic PJ, Zenati MS, Munera V, Pribis JP, Ochoa JB (2010) Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. J Trauma 68:843\u2013852","journal-title":"J Trauma"},{"key":"829_CR13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41590-022-01189-z","volume":"23","author":"F Calzetti","year":"2022","unstructured":"Calzetti F, Finotti G, Tamassia N, Bianchetto-Aguilera F, Castellucci M, Cane S, Lonardi S, Cavallini C, Matte A, Gasperini S et al (2022) CD66b(-)CD64(dim)CD115(-) cells in the human bone marrow represent neutrophil-committed progenitors. Nat Immunol 23:679\u2013691","journal-title":"Nat Immunol"},{"key":"829_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41577-024-01098-2","volume":"25","author":"S Cane","year":"2025","unstructured":"Cane S, Geiger R, Bronte V (2025) The roles of arginases and arginine in immunity. Nat Rev Immunol 25:266\u2013284","journal-title":"Nat Rev Immunol"},{"key":"829_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/imm.13040","volume":"156","author":"Y Cao","year":"2019","unstructured":"Cao Y, He Y, Wang X, Liu Y, Shi K, Zheng Z, Su X, Lei A, He J, Zhou J (2019) Polymorphonuclear myeloid-derived suppressor cells attenuate allergic airway inflammation by negatively regulating group 2 innate lymphoid cells. Immunology 156:402\u2013412","journal-title":"Immunology"},{"key":"829_CR16","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/imr.13161","volume":"314","author":"C Carmona-Rivera","year":"2023","unstructured":"Carmona-Rivera C, Kaplan MJ (2023) Low-density granulocytes in systemic autoimmunity and autoinflammation. Immunol Rev 314:313\u2013325","journal-title":"Immunol Rev"},{"key":"829_CR17","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/icb.2017.4","volume":"95","author":"S Casacuberta-Serra","year":"2017","unstructured":"Casacuberta-Serra S, Pares M, Golbano A, Coves E, Espejo C, Barquinero J (2017) Myeloid-derived suppressor cells can be efficiently generated from human hematopoietic progenitors and peripheral blood monocytes. Immunol Cell Biol 95:538\u2013548","journal-title":"Immunol Cell Biol"},{"key":"829_CR18","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00262-019-02302-2","volume":"68","author":"L Cassetta","year":"2019","unstructured":"Cassetta L, Baekkevold ES, Brandau S, Bujko A, Cassatella MA, Dorhoi A, Krieg C, Lin A, Lore K, Marini O et al (2019) Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates. Cancer Immunol Immunother 68:687\u2013697","journal-title":"Cancer Immunol Immunother"},{"key":"829_CR19","doi-asserted-by":"publisher","first-page":"e001223","DOI":"10.1136\/jitc-2020-001223","volume":"8","author":"L Cassetta","year":"2020","unstructured":"Cassetta L, Bruderek K, Skrzeczynska-Moncznik J, Osiecka O, Hu X, Rundgren IM, Lin A, Santegoets K, Horzum U, Godinho-Santos A et al (2020) Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation. J Immunother Cancer 8:e001223","journal-title":"J Immunother Cancer"},{"key":"829_CR20","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.2147\/CMAR.S210545","volume":"11","author":"E Chai","year":"2019","unstructured":"Chai E, Zhang L, Li C (2019) LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression. Cancer Manag Res 11:7307\u20137315","journal-title":"Cancer Manag Res"},{"key":"829_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adz2273","volume":"10","author":"TG Chang","year":"2025","unstructured":"Chang TG, Friedman J, Clavijo PE, Robbins Y, Craveiro M, Huynh A, Dar MS, Yang X, Cao Y, Sievers CM et al (2025) Hypoxia-induced EGR1 remodels neutrophils to suppress antitumor immunity. Sci Immunol 10:eadz2273","journal-title":"Sci Immunol"},{"key":"829_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-92417-7","volume":"15","author":"A Charoensappakit","year":"2025","unstructured":"Charoensappakit A, Sae-Khow K, Vutthikraivit N, Maneesow P, Sriprasart T, Pachinburavan M, Leelahavanichkul A (2025) Immune suppressive activities of low-density neutrophils in sepsis and potential use as a novel biomarker of sepsis-induced immune suppression. Sci Rep 15:9458","journal-title":"Sci Rep"},{"key":"829_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13277-011-0254-6","volume":"33","author":"J Choi","year":"2012","unstructured":"Choi J, Suh B, Ahn YO, Kim TM, Lee JO, Lee SH, Heo DS (2012) CD15+\/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function. Tumour Biol 33:121\u2013129","journal-title":"Tumour Biol"},{"key":"829_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104317","volume":"363","author":"KE Cole","year":"2021","unstructured":"Cole KE, Ly QP, Hollingsworth MA, Cox JL, Padussis JC, Foster JM, Vargas LM, Talmadge JE (2021) Human splenic myeloid derived suppressor cells: phenotypic and clustering analysis. Cell Immunol 363:104317","journal-title":"Cell Immunol"},{"key":"829_CR25","doi-asserted-by":"crossref","unstructured":"Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C et al (2016) Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci Immunol 1:aaf8943","DOI":"10.1126\/sciimmunol.aaf8943"},{"key":"829_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/JLB.4COVBCR0321-129R","volume":"111","author":"R Coudereau","year":"2022","unstructured":"Coudereau R, Waeckel L, Cour M, Rimmele T, Pescarmona R, Fabri A, Jallades L, Yonis H, Gossez M, Lukaszewicz AC et al (2022) Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome. J Leukoc Biol 111:489\u2013496","journal-title":"J Leukoc Biol"},{"key":"829_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2406748121","volume":"121","author":"A Dahal","year":"2024","unstructured":"Dahal A, Hong Y, Mathew JS, Geber A, Eckl S, Renner S, Sailer CJ, Ryan AT, Mir S, Lim K et al (2024) Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors. Proc Natl Acad Sci USA 121:e2406748121","journal-title":"Proc Natl Acad Sci USA"},{"key":"829_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/cc14003","volume":"18","author":"CJ Darcy","year":"2014","unstructured":"Darcy CJ, Minigo G, Piera KA, Davis JS, McNeil YR, Chen Y, Volkheimer AD, Weinberg JB, Anstey NM, Woodberry T (2014) Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care 18:R163","journal-title":"Crit Care"},{"key":"829_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36218","volume":"10","author":"XH Deng","year":"2024","unstructured":"Deng XH, Huang LX, Sun Q, Li CG, Xie YC, Liu XQ, Fu QL (2024) Increased circulating LOX-1(+) neutrophils activate T cells and demonstrate a pro-inflammatory role in allergic rhinitis. Heliyon 10:e36218","journal-title":"Heliyon"},{"key":"829_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1006\/bcmd.2002.0513","volume":"28","author":"MT Elghetany","year":"2002","unstructured":"Elghetany MT (2002) Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol Dis 28:260\u2013274","journal-title":"Blood Cells Mol Dis"},{"key":"829_CR31","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1158\/2326-6066.CIR-20-0922","volume":"9","author":"TR Emmons","year":"2021","unstructured":"Emmons TR, Giridharan T, Singel KL, Khan ANH, Ricciuti J, Howard K, Silva-Del Toro SL, Debreceni IL, Aarts CEM, Brouwer MC et al (2021) Mechanisms driving neutrophil-induced T-cell immunoparalysis in ovarian cancer. Cancer Immunol Res 9:790\u2013810","journal-title":"Cancer Immunol Res"},{"key":"829_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41590-024-02029-y","volume":"26","author":"E Eruslanov","year":"2025","unstructured":"Eruslanov E, Nefedova Y, Gabrilovich DI (2025) The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting. Nat Immunol 26:17\u201328","journal-title":"Nat Immunol"},{"key":"829_CR33","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/ijc.26123","volume":"130","author":"E Eruslanov","year":"2012","unstructured":"Eruslanov E, Neuberger M, Daurkin I, Perrin GQ, Algood C, Dahm P, Rosser C, Vieweg J, Gilbert SM, Kusmartsev S (2012) Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer 130:1109\u20131119","journal-title":"Int J Cancer"},{"key":"829_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.trecan.2016.12.006","volume":"3","author":"EB Eruslanov","year":"2017","unstructured":"Eruslanov EB, Singhal S, Albelda SM (2017) Mouse versus human neutrophils in cancer: a major knowledge gap. Trends Cancer 3:149\u2013160","journal-title":"Trends Cancer"},{"key":"829_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1158\/0008-5472.CAN-06-3037","volume":"67","author":"DI Gabrilovich","year":"2007","unstructured":"Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H (2007) The terminology issue for myeloid-derived suppressor cells. Cancer Res 67:425","journal-title":"Cancer Res"},{"key":"829_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1461455","volume":"15","author":"O Goldmann","year":"2024","unstructured":"Goldmann O, Medina E (2024) Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells. Front Immunol 15:1461455","journal-title":"Front Immunol"},{"key":"829_CR37","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.3390\/cancers13061362","volume":"13","author":"F Gondois-Rey","year":"2021","unstructured":"Gondois-Rey F, Paul M, Alcaraz F, Bourass S, Monnier J, Malissen N, Grob JJ, Bruger AM, Van Der Bruggen P, Gaudy-Marqueste C et al (2021) Identification of an immature subset of PMN-MDSC correlated to response to checkpoint inhibitor therapy in patients with metastatic melanoma. Cancers 13:1362","journal-title":"Cancers"},{"key":"829_CR38","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","volume":"121","author":"GT Gorgun","year":"2013","unstructured":"Gorgun GT, Whitehill G, Anderson JL, Hideshima T, Maguire C, Laubach J, Raje N, Munshi NC, Richardson PG, Anderson KC (2013) Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 121:2975\u20132987","journal-title":"Blood"},{"key":"829_CR39","doi-asserted-by":"crossref","unstructured":"Grover A, Tcyganov EN, Gabrilovich DI (2025) Myeloid cell reprogramming and immune suppression. Annu Rev Physiol 88:437\u2013457","DOI":"10.1146\/annurev-physiol-050824-111031"},{"key":"829_CR40","doi-asserted-by":"publisher","first-page":"qiae220","DOI":"10.1093\/jleuko\/qiae220","volume":"117","author":"R Guo","year":"2025","unstructured":"Guo R, Xie X, Ren Q, Liew PX (2025) New insights on extramedullary granulopoiesis and neutrophil heterogeneity in the spleen and its importance in disease. J Leukoc Biol 117:qiae220","journal-title":"J Leukoc Biol"},{"key":"829_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/imm.12004","volume":"137","author":"BD Hock","year":"2012","unstructured":"Hock BD, Taylor KG, Cross NB, Kettle AJ, Hampton MB, McKenzie JL (2012) Effect of activated human polymorphonuclear leucocytes on T lymphocyte proliferation and viability. Immunology 137:249\u2013258","journal-title":"Immunology"},{"key":"829_CR42","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1182\/blood-2006-06-032599","volume":"109","author":"LC Jacobsen","year":"2007","unstructured":"Jacobsen LC, Theilgaard-Monch K, Christensen EI, Borregaard N (2007) Arginase 1 is expressed in myelocytes\/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood 109:3084\u20133087","journal-title":"Blood"},{"key":"829_CR43","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1189\/jlb.5HI0214-074R","volume":"96","author":"H Janols","year":"2014","unstructured":"Janols H, Bergenfelz C, Allaoui R, Larsson AM, Ryden L, Bjornsson S, Janciauskiene S, Wullt M, Bredberg A, Leandersson K (2014) A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol 96:685\u2013693","journal-title":"J Leukoc Biol"},{"key":"829_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00262-016-1953-z","volume":"66","author":"KR Jordan","year":"2017","unstructured":"Jordan KR, Kapoor P, Spongberg E, Tobin RP, Gao D, Borges VF, McCarter MD (2017) Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients. Cancer Immunol Immunother 66:503\u2013513","journal-title":"Cancer Immunol Immunother"},{"key":"829_CR45","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1097\/JTO.0000000000000617","volume":"10","author":"K Kadota","year":"2015","unstructured":"Kadota K, Nitadori JI, Ujiie H, Buitrago DH, Woo KM, Sima CS, Travis WD, Jones DR, Adusumilli PS (2015) Prognostic impact of immune microenvironment in lung squamous cell carcinoma: tumor-infiltrating CD10+ neutrophil\/CD20+ lymphocyte ratio as an independent prognostic factor. J Thorac Oncol 10:1301\u20131310","journal-title":"J Thorac Oncol"},{"key":"829_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1164\/rccm.201808-1502LE","volume":"199","author":"HR Kim","year":"2019","unstructured":"Kim HR, Park SM, Seo SU, Jung I, Yoon HI, Gabrilovich DI, Cho BC, Seong SY, Ha SJ, Youn JI (2019) The ratio of peripheral regulatory T cells to Lox-1(+) polymorphonuclear myeloid-derived suppressor cells predicts the early response to anti-PD-1 therapy in patients with non-small cell lung cancer. Am J Respir Crit Care Med 199:243\u2013246","journal-title":"Am J Respir Crit Care Med"},{"key":"829_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-024-01244-9","volume":"22","author":"L Koenderman","year":"2025","unstructured":"Koenderman L, Vrisekoop N (2025) Neutrophils in cancer: from biology to therapy. Cell Mol Immunol 22:4\u201323","journal-title":"Cell Mol Immunol"},{"key":"829_CR48","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.4049\/jimmunol.1500340","volume":"196","author":"N Kostlin","year":"2016","unstructured":"Kostlin N, Hofstadter K, Ostermeir AL, Spring B, Leiber A, Haen S, Abele H, Bauer P, Pollheimer J, Hartl D et al (2016) Granulocytic myeloid-derived suppressor cells accumulate in human placenta and polarize toward a Th2 phenotype. J Immunol 196:1132\u20131145","journal-title":"J Immunol"},{"key":"829_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.584712","volume":"11","author":"N Kostlin-Gille","year":"2020","unstructured":"Kostlin-Gille N, Gille C (2020) Myeloid-derived suppressor cells in pregnancy and the neonatal period. Front Immunol 11:584712","journal-title":"Front Immunol"},{"key":"829_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100632","volume":"22","author":"J Krumm","year":"2023","unstructured":"Krumm J, Petrova E, Lechner S, Mergner J, Boehm HH, Prestipino A, Steinbrunn D, Deline ML, Koetzner L, Schindler C et al (2023) High-throughput screening and proteomic characterization of compounds targeting myeloid-derived suppressor cells. Mol Cell Proteomics 22:100632","journal-title":"Mol Cell Proteomics"},{"key":"829_CR51","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41590-023-01490-5","volume":"24","author":"AJ Kwok","year":"2023","unstructured":"Kwok AJ, Allcock A, Ferreira RC, Cano-Gamez E, Smee M, Burnham KL, Zurke YX, Emergency Medicine Research O, McKechnie S, Mentzer AJ et al (2023) Neutrophils and emergency granulopoiesis drive immune suppression and an extreme response endotype during sepsis. Nat Immunol 24:767\u2013779","journal-title":"Nat Immunol"},{"key":"829_CR52","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1158\/1078-0432.CCR-17-3726","volume":"24","author":"S Lang","year":"2018","unstructured":"Lang S, Bruderek K, Kaspar C, Hoing B, Kanaan O, Dominas N, Hussain T, Droege F, Eyth C, Hadaschik B et al (2018) Clinical relevance and suppressive capacity of human myeloid-derived suppressor cell subsets. Clin Cancer Res 24:4834\u20134844","journal-title":"Clin Cancer Res"},{"key":"829_CR53","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2521396","volume":"14","author":"C Lattanzi","year":"2025","unstructured":"Lattanzi C, Bianchetto-Aguilera F, Donini M, Pettinella F, Caveggion E, Castellucci M, Gasperini S, Mariotti B, Signoretto I, Cantini M et al (2025) Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humans. Oncoimmunology 14:2521396","journal-title":"Oncoimmunology"},{"key":"829_CR54","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.4049\/jimmunol.1000901","volume":"185","author":"MG Lechner","year":"2010","unstructured":"Lechner MG, Liebertz DJ, Epstein AL (2010) Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells. J Immunol 185:2273\u20132284","journal-title":"J Immunol"},{"key":"829_CR55","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.imlet.2017.07.003","volume":"188","author":"FJN Lelis","year":"2017","unstructured":"Lelis FJN, Jaufmann J, Singh A, Fromm K, Teschner AC, Poschel S, Schafer I, Beer-Hammer S, Rieber N, Hartl D (2017) Myeloid-derived suppressor cells modulate B-cell responses. Immunol Lett 188:108\u2013115","journal-title":"Immunol Lett"},{"key":"829_CR56","doi-asserted-by":"publisher","first-page":"e141683","DOI":"10.1172\/jci.insight.141683","volume":"6","author":"H Lewinsky","year":"2021","unstructured":"Lewinsky H, Gunes EG, David K, Radomir L, Kramer MP, Pellegrino B, Perpinial M, Chen J, He TF, Mansour AG et al (2021) CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma. JCI Insight 6:e141683","journal-title":"JCI Insight"},{"key":"829_CR57","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1093\/humrep\/deaa217","volume":"35","author":"C Li","year":"2020","unstructured":"Li C, Chen C, Kang X, Zhang X, Sun S, Guo F, Wang Q, Kou X, Bai W, Zhao A (2020) Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils. Hum Reprod 35:2677\u20132691","journal-title":"Hum Reprod"},{"key":"829_CR58","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/JLB.3MA0821-029R","volume":"110","author":"X Li","year":"2021","unstructured":"Li X, Liu J, Xing Z, Tang J, Sun H, Zhang X, Lv S, Chen Z, Shi M, Chen M et al (2021) Polymorphonuclear myeloid-derived suppressor cells link inflammation and damage response after trauma. J Leukoc Biol 110:1143\u20131161","journal-title":"J Leukoc Biol"},{"key":"829_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1100756","volume":"9","author":"M Liu","year":"2022","unstructured":"Liu M, Wang G, Wang L, Wang Y, Bian Y, Shi H, Liu J (2022) Immunoregulatory functions of mature CD10(+) and immature CD10(-) neutrophils in sepsis patients. Front Med 9:1100756","journal-title":"Front Med"},{"key":"829_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clim.2012.01.011","volume":"143","author":"A Luyckx","year":"2012","unstructured":"Luyckx A, Schouppe E, Rutgeerts O, Lenaerts C, Fevery S, Devos T, Dierickx D, Waer M, Van Ginderachter JA, Billiau AD (2012) G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol 143:83\u201387","journal-title":"Clin Immunol"},{"key":"829_CR61","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nri3660","volume":"14","author":"MG Manz","year":"2014","unstructured":"Manz MG, Boettcher S (2014) Emergency granulopoiesis. Nat Rev Immunol 14:302\u2013314","journal-title":"Nat Rev Immunol"},{"key":"829_CR62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","volume":"32","author":"I Marigo","year":"2010","unstructured":"Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, Dolcetti L, Ugel S, Sonda N, Bicciato S, Falisi E et al (2010) Tumor-induced tolerance and immune suppression depend on the C\/EBPbeta transcription factor. Immunity 32:790\u2013802","journal-title":"Immunity"},{"key":"829_CR63","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1182\/blood-2016-04-713206","volume":"129","author":"O Marini","year":"2017","unstructured":"Marini O, Costa S, Bevilacqua D, Calzetti F, Tamassia N, Spina C, De Sabata D, Tinazzi E, Lunardi C, Scupoli MT et al (2017) Mature CD10(+) and immature CD10(-) neutrophils present in G-CSF-treated donors display opposite effects on T cells. Blood 129:1343\u20131356","journal-title":"Blood"},{"key":"829_CR64","doi-asserted-by":"publisher","first-page":"e202000893","DOI":"10.26508\/lsa.202000893","volume":"3","author":"M Mehmeti-Ajradini","year":"2020","unstructured":"Mehmeti-Ajradini M, Bergenfelz C, Larsson AM, Carlsson R, Riesbeck K, Ahl J, Janols H, Wullt M, Bredberg A, Kallberg E et al (2020) Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer. Life Sci Alliance 3:e202000893","journal-title":"Life Sci Alliance"},{"key":"829_CR65","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41590-022-01311-1","volume":"23","author":"E Montaldo","year":"2022","unstructured":"Montaldo E, Lusito E, Bianchessi V, Caronni N, Scala S, Basso-Ricci L, Cantaffa C, Masserdotti A, Barilaro M, Barresi S et al (2022) Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress. Nat Immunol 23:1470\u20131483","journal-title":"Nat Immunol"},{"key":"829_CR66","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1182\/blood-2004-07-2521","volume":"105","author":"M Munder","year":"2005","unstructured":"Munder M, Mollinedo F, Calafat J, Canchado J, Gil-Lamaignere C, Fuentes JM, Luckner C, Doschko G, Soler G, Eichmann K et al (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105:2549\u20132556","journal-title":"Blood"},{"key":"829_CR67","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/imm.12876","volume":"154","author":"J Nan","year":"2018","unstructured":"Nan J, Xing YF, Hu B, Tang JX, Dong HM, He YM, Ruan DY, Ye QJ, Cai JR, Ma XK et al (2018) Endoplasmic reticulum stress induced LOX-1(+) CD15(+) polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma. Immunology 154:144\u2013155","journal-title":"Immunology"},{"key":"829_CR68","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/imr.13154","volume":"314","author":"WM Nauseef","year":"2023","unstructured":"Nauseef WM (2023) Human neutrophils not equal murine neutrophils: does it matter? Immunol Rev 314:442\u2013456","journal-title":"Immunol Rev"},{"key":"829_CR69","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.immuni.2025.07.011","volume":"58","author":"LG Ng","year":"2025","unstructured":"Ng LG, Ballesteros I, Cassatella MA, Egeblad M, Fridlender ZG, Gabrilovich D, Gao Q, Granot Z, Grieshaber-Bouyer R, Grimes HL et al (2025) From complexity to consensus: a roadmap for neutrophil classification. Immunity 58:1890\u20131903","journal-title":"Immunity"},{"key":"829_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6493","volume":"383","author":"MSF Ng","year":"2024","unstructured":"Ng MSF, Kwok I, Tan L, Shi C, Cerezo-Wallis D, Tan Y, Leong K, Calvo GF, Yang K, Zhang Y et al (2024) Deterministic reprogramming of neutrophils within tumors. Science 383:eadf6493","journal-title":"Science"},{"key":"829_CR71","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.4049\/jimmunol.2200914","volume":"210","author":"S Ostrand-Rosenberg","year":"2023","unstructured":"Ostrand-Rosenberg S, Lamb TJ, Pawelec G (2023) Here, there, and everywhere: myeloid-derived suppressor cells in immunology. J Immunol 210:1183\u20131197","journal-title":"J Immunol"},{"key":"829_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3389\/fimmu.2019.00183","volume":"10","author":"MY Park","year":"2019","unstructured":"Park MY, Lim BG, Kim SY, Sohn HJ, Kim S, Kim TG (2019) GM-CSF promotes the expansion and differentiation of cord blood myeloid-derived suppressor cells, which attenuate xenogeneic graft-vs.-host disease. Front Immunol 10:183","journal-title":"Front Immunol"},{"key":"829_CR73","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.4049\/jimmunol.1502690","volume":"197","author":"CC Pedersen","year":"2016","unstructured":"Pedersen CC, Borup R, Fischer-Nielsen A, Mora-Jensen H, Fossum A, Cowland JB, Borregaard N (2016) Changes in gene expression during G-CSF-induced emergency granulopoiesis in humans. J Immunol 197:1989\u20131999","journal-title":"J Immunol"},{"key":"829_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.657329","volume":"12","author":"A Pelosi","year":"2021","unstructured":"Pelosi A, Besi F, Tumino N, Merli P, Quatrini L, Li Pira G, Algeri M, Moretta L, Vacca P (2021) NK cells and PMN-MDSCs in the graft from G-CSF mobilized haploidentical donors display distinct gene expression profiles from those of the non-mobilized counterpart. Front Immunol 12:657329","journal-title":"Front Immunol"},{"key":"829_CR75","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1182\/blood.2019004537","volume":"136","author":"C Perez","year":"2020","unstructured":"Perez C, Botta C, Zabaleta A, Puig N, Cedena MT, Goicoechea I, Alameda D, San Jose-Eneriz E, Merino J, Rodriguez-Otero P et al (2020) Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma. Blood 136:199\u2013209","journal-title":"Blood"},{"key":"829_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101380","volume":"5","author":"F Pettinella","year":"2024","unstructured":"Pettinella F, Mariotti B, Lattanzi C, Bruderek K, Donini M, Costa S, Marini O, Iannoto G, Gasperini S, Caveggion E et al (2024) Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors. Cell Rep Med 5:101380","journal-title":"Cell Rep Med"},{"key":"829_CR77","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI57990","volume":"122","author":"J Pillay","year":"2012","unstructured":"Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, Ulfman LH, Leenen LP, Pickkers P, Koenderman L (2012) A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest 122:327\u2013336","journal-title":"J Clin Invest"},{"key":"829_CR78","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1007\/s00018-013-1286-4","volume":"70","author":"J Pillay","year":"2013","unstructured":"Pillay J, Tak T, Kamp VM, Koenderman L (2013) Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell Mol Life Sci 70:3813\u20133827","journal-title":"Cell Mol Life Sci"},{"key":"829_CR79","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1158\/0008-5472.CAN-19-2843","volume":"80","author":"C Porta","year":"2020","unstructured":"Porta C, Consonni FM, Morlacchi S, Sangaletti S, Bleve A, Totaro MG, Larghi P, Rimoldi M, Tripodo C, Strauss L et al (2020) Tumor-derived prostaglandin E2 promotes p50 NF-kappaB-dependent differentiation of monocytic MDSCs. Cancer Res 80:2874\u20132888","journal-title":"Cancer Res"},{"key":"829_CR80","doi-asserted-by":"publisher","first-page":"e20220011","DOI":"10.1084\/jem.20220011","volume":"219","author":"DF Quail","year":"2022","unstructured":"Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, Goodridge HS, Granot Z, Hidalgo A, Huttenlocher A et al (2022) Neutrophil phenotypes and functions in cancer: a consensus statement. J Exp Med 219:e20220011","journal-title":"J Exp Med"},{"key":"829_CR81","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1182\/blood.2023022666","volume":"143","author":"P Quaranta","year":"2024","unstructured":"Quaranta P, Basso-Ricci L, Jofra Hernandez R, Pacini G, Naldini MM, Barcella M, Seffin L, Pais G, Spinozzi G, Benedicenti F et al (2024) Circulating hematopoietic stem\/progenitor cell subsets contribute to human hematopoietic homeostasis. Blood 143:1937\u20131952","journal-title":"Blood"},{"key":"829_CR82","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/annrheumdis-2018-214620","volume":"78","author":"S Rahman","year":"2019","unstructured":"Rahman S, Sagar D, Hanna RN, Lightfoot YL, Mistry P, Smith CK, Manna Z, Hasni S, Siegel RM, Sanjuan MA et al (2019) Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus. Ann Rheum Dis 78:957\u2013966","journal-title":"Ann Rheum Dis"},{"key":"829_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/cei.12143","volume":"174","author":"N Rieber","year":"2013","unstructured":"Rieber N, Gille C, Kostlin N, Schafer I, Spring B, Ost M, Spieles H, Kugel HA, Pfeiffer M, Heininger V et al (2013) Neutrophilic myeloid-derived suppressor cells in cord blood modulate innate and adaptive immune responses. Clin Exp Immunol 174:45\u201352","journal-title":"Clin Exp Immunol"},{"key":"829_CR84","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","volume":"69","author":"PC Rodriguez","year":"2009","unstructured":"Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, Ochoa AC (2009) Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res 69:1553\u20131560","journal-title":"Cancer Res"},{"key":"829_CR85","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.celrep.2017.09.018","volume":"21","author":"J Rodriguez-Ubreva","year":"2017","unstructured":"Rodriguez-Ubreva J, Catala-Moll F, Obermajer N, Alvarez-Errico D, Ramirez RN, Company C, Vento-Tormo R, Moreno-Bueno G, Edwards RP, Mortazavi A et al (2017) Prostaglandin E2 leads to the acquisition of DNMT3A-dependent tolerogenic functions in human myeloid-derived suppressor cells. Cell Rep 21:154\u2013167","journal-title":"Cell Rep"},{"key":"829_CR86","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ijc.24448","volume":"125","author":"R Rotondo","year":"2009","unstructured":"Rotondo R, Barisione G, Mastracci L, Grossi F, Orengo AM, Costa R, Truini M, Fabbi M, Ferrini S, Barbieri O (2009) IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. Int J Cancer 125:887\u2013893","journal-title":"Int J Cancer"},{"key":"829_CR87","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1189\/jlb.1109737","volume":"89","author":"R Rotondo","year":"2011","unstructured":"Rotondo R, Bertolotto M, Barisione G, Astigiano S, Mandruzzato S, Ottonello L, Dallegri F, Bronte V, Ferrini S, Barbieri O (2011) Exocytosis of azurophil and arginase 1-containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J Leukoc Biol 89:721\u2013727","journal-title":"J Leukoc Biol"},{"key":"829_CR88","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","volume":"40","author":"S Salcher","year":"2022","unstructured":"Salcher S, Sturm G, Horvath L, Untergasser G, Kuempers C, Fotakis G, Panizzolo E, Martowicz A, Trebo M, Pall G et al (2022) High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell 40:1503\u20131520.e1508","journal-title":"Cancer Cell"},{"key":"829_CR89","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.18632\/oncotarget.28135","volume":"12","author":"DP Saraiva","year":"2021","unstructured":"Saraiva DP, Correia BF, Salvador R, de Sousa N, Jacinto A, Braga S, Cabral MG (2021) Circulating low density neutrophils of breast cancer patients are associated with their worse prognosis due to the impairment of T cell responses. Oncotarget 12:2388\u20132403","journal-title":"Oncotarget"},{"key":"829_CR90","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imr.12448","volume":"273","author":"P Scapini","year":"2016","unstructured":"Scapini P, Marini O, Tecchio C, Cassatella MA (2016) Human neutrophils in the saga of cellular heterogeneity: insights and open questions. Immunol Rev 273:48\u201360","journal-title":"Immunol Rev"},{"key":"829_CR91","first-page":"4756","volume":"61","author":"J Schmielau","year":"2001","unstructured":"Schmielau J, Finn OJ (2001) Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 61:4756\u20134760","journal-title":"Cancer Res"},{"key":"829_CR92","doi-asserted-by":"publisher","first-page":"eaaw9159","DOI":"10.1126\/sciimmunol.aaw9159","volume":"4","author":"Y Si","year":"2019","unstructured":"Si Y, Merz SF, Jansen P, Wang B, Bruderek K, Altenhoff P, Mattheis S, Lang S, Gunzer M, Klode J et al (2019) Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue. Sci Immunol 4:eaaw9159","journal-title":"Sci Immunol"},{"key":"829_CR93","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41423-025-01259-w","volume":"22","author":"I Signoretto","year":"2025","unstructured":"Signoretto I, Calzetti F, Finotti G, Lonardi S, Balanzin C, Bianchetto-Aguilera F, Gasperini S, Gardiman E, Castellucci M, Russignan A et al (2025) Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis. Cell Mol Immunol 22:316\u2013329","journal-title":"Cell Mol Immunol"},{"key":"829_CR94","doi-asserted-by":"publisher","first-page":"e122311","DOI":"10.1172\/jci.insight.122311","volume":"4","author":"KL Singel","year":"2019","unstructured":"Singel KL, Emmons TR, Khan ANH, Mayor PC, Shen S, Wong JT, Morrell K, Eng KH, Mark J, Bankert RB et al (2019) Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment. JCI Insight 4:e122311","journal-title":"JCI Insight"},{"key":"829_CR95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-0716-1060-2_8","volume":"2236","author":"A Singh","year":"2021","unstructured":"Singh A, Rieber N (2021) In vitro generation of human neutrophilic myeloid-derived suppressor cells. Methods Mol Biol 2236:77\u201383","journal-title":"Methods Mol Biol"},{"key":"829_CR96","doi-asserted-by":"publisher","first-page":"6992","DOI":"10.1158\/1078-0432.CCR-11-1107","volume":"17","author":"TR Sippel","year":"2011","unstructured":"Sippel TR, White J, Nag K, Tsvankin V, Klaassen M, Kleinschmidt-DeMasters BK, Waziri A (2011) Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res 17:6992\u20137002","journal-title":"Clin Cancer Res"},{"key":"829_CR97","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1182\/blood-2010-12-325753","volume":"118","author":"S Solito","year":"2011","unstructured":"Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A, Francescato S, Basso G, Zanovello P, Onicescu G et al (2011) A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 118:2254\u20132265","journal-title":"Blood"},{"key":"829_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1570121","volume":"15","author":"CD St Laurent","year":"2025","unstructured":"St Laurent CD, Jame-Chenarboo Z, Beck AE, Stubblefield S, Duan S, Sigal D, Macauley MS (2025) CD16 and Siglec expression refine the phenotypic heterogeneity of steady-state myeloid-derived suppressor cells. Front Oncol 15:1570121","journal-title":"Front Oncol"},{"key":"829_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04682-x","volume":"12","author":"R Sun","year":"2022","unstructured":"Sun R, Huang J, Yang Y, Liu L, Shao Y, Li L, Sun B (2022) Dysfunction of low-density neutrophils in peripheral circulation in patients with sepsis. Sci Rep 12:685","journal-title":"Sci Rep"},{"key":"829_CR100","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nrc3581","volume":"13","author":"JE Talmadge","year":"2013","unstructured":"Talmadge JE, Gabrilovich DI (2013) History of myeloid-derived suppressor cells. Nat Rev Cancer 13:739\u2013752","journal-title":"Nat Rev Cancer"},{"key":"829_CR101","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/eji.202048666","volume":"50","author":"E Tavukcuoglu","year":"2020","unstructured":"Tavukcuoglu E, Horzum U, Yanik H, Uner A, Yoyen-Ermis D, Nural SK, Aydin B, Sokmensuer C, Karakoc D, Yilmaz KB et al (2020) Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer. Eur J Immunol 50:2067\u20132074","journal-title":"Eur J Immunol"},{"key":"829_CR102","first-page":"204","volume":"51","author":"Y Tsuda","year":"2012","unstructured":"Tsuda Y, Fukui H, Asai A, Fukunishi S, Miyaji K, Fujiwara S, Teramura K, Fukuda A, Higuchi K (2012) An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma. J Clin Biochem Nutr 51:204\u2013212","journal-title":"J Clin Biochem Nutr"},{"key":"829_CR103","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41375-019-0585-7","volume":"34","author":"N Tumino","year":"2020","unstructured":"Tumino N, Besi F, Di Pace AL, Mariotti FR, Merli P, Li Pira G, Galaverna F, Pitisci A, Ingegnere T, Pelosi A et al (2020) PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation. Leukemia 34:932\u2013937","journal-title":"Leukemia"},{"key":"829_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803014","volume":"12","author":"N Tumino","year":"2021","unstructured":"Tumino N, Besi F, Martini S, Di Pace AL, Munari E, Quatrini L, Pelosi A, Fiore PF, Fiscon G, Paci P et al (2021) Polymorphonuclear myeloid-derived suppressor cells are abundant in peripheral blood of cancer patients and suppress natural killer cell anti-tumor activity. Front Immunol 12:803014","journal-title":"Front Immunol"},{"key":"829_CR105","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1158\/2159-8290.CD-24-1056","volume":"15","author":"A Ugolini","year":"2025","unstructured":"Ugolini A, De Leo A, Yu X, Scirocchi F, Liu X, Peixoto B, Scocozza D, Pace A, Perego M, Gardini A et al (2025) Functional reprogramming of neutrophils within the brain tumor microenvironment by hypoxia-driven histone lactylation. Cancer Discov 15:1270\u20131296","journal-title":"Cancer Discov"},{"key":"829_CR106","doi-asserted-by":"publisher","first-page":"e138581","DOI":"10.1172\/jci.insight.138581","volume":"5","author":"A Ugolini","year":"2020","unstructured":"Ugolini A, Tyurin VA, Tyurina YY, Tcyganov EN, Donthireddy L, Kagan VE, Gabrilovich DI, Veglia F (2020) Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer. JCI Insight 5:e138581","journal-title":"JCI Insight"},{"key":"829_CR107","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.201606-1143OC","volume":"196","author":"F Uhel","year":"2017","unstructured":"Uhel F, Azzaoui I, Gregoire M, Pangault C, Dulong J, Tadie JM, Gacouin A, Camus C, Cynober L, Fest T et al (2017) Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis. Am J Respir Crit Care Med 196:315\u2013327","journal-title":"Am J Respir Crit Care Med"},{"key":"829_CR108","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1089\/wound.2021.0065","volume":"11","author":"N Urao","year":"2022","unstructured":"Urao N, Liu J, Takahashi K, Ganesh G (2022) Hematopoietic stem cells in wound healing response. Adv Wound Care 11:598\u2013621","journal-title":"Adv Wound Care"},{"key":"829_CR109","doi-asserted-by":"crossref","unstructured":"Vanhaver C, Aboubakar Nana F, Delhez N, Luyckx M, Hirsch T, Bayard A, Houbion C, Dauguet N, Brochier A, van der Bruggen P et al (2024) Immunosuppressive low-density neutrophils in the blood of cancer patients display a mature phenotype. Life Sci Alliance 7:e202302332","DOI":"10.26508\/lsa.202302332"},{"key":"829_CR110","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/14653240310002252","volume":"5","author":"ZF Vasconcelos","year":"2003","unstructured":"Vasconcelos ZF, Santos BM, Costa ES, Lima M, Tabak DG, Bouzas LF, Azevedo WM, Barcinski MA, Bonomo A (2003) T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes. Cytotherapy 5:336\u2013345","journal-title":"Cytotherapy"},{"key":"829_CR111","doi-asserted-by":"publisher","first-page":"e20201803","DOI":"10.1084\/jem.20201803","volume":"218","author":"F Veglia","year":"2021","unstructured":"Veglia F, Hashimoto A, Dweep H, Sanseviero E, De Leo A, Tcyganov E, Kossenkov A, Mulligan C, Nam B, Masters G et al (2021) Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. J Exp Med 218:e20201803","journal-title":"J Exp Med"},{"key":"829_CR112","doi-asserted-by":"publisher","first-page":"F31","DOI":"10.1097\/QAD.0b013e328354b43f","volume":"26","author":"T Vollbrecht","year":"2012","unstructured":"Vollbrecht T, Stirner R, Tufman A, Roider J, Huber RM, Bogner JR, Lechner A, Bourquin C, Draenert R (2012) Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 26:F31\u2013F37","journal-title":"AIDS"},{"key":"829_CR113","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/gutjnl-2021-326070","volume":"72","author":"L Wang","year":"2023","unstructured":"Wang L, Liu Y, Dai Y, Tang X, Yin T, Wang C, Wang T, Dong L, Shi M, Qin J et al (2023) Single-cell RNA-seq analysis reveals BHLHE40-driven pro-tumour neutrophils with hyperactivated glycolysis in pancreatic tumour microenvironment. Gut 72:958\u2013971","journal-title":"Gut"},{"key":"829_CR114","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","volume":"187","author":"Y Wu","year":"2024","unstructured":"Wu Y, Ma J, Yang X, Nan F, Zhang T, Ji S, Rao D, Feng H, Gao K, Gu X et al (2024) Neutrophil profiling illuminates anti-tumor antigen-presenting potency. Cell 187:1422\u20131439.e1424","journal-title":"Cell"},{"key":"829_CR115","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue R, Zhang Q, Cao Q, Kong R, Xiang X, Liu H, Feng M, Wang F, Cheng J, Li Z et al (2022) Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612:141\u2013147","journal-title":"Nature"},{"key":"829_CR116","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1158\/0008-5472.CAN-04-4505","volume":"65","author":"AH Zea","year":"2005","unstructured":"Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signoretti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O\u2019Neill A et al (2005) Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res 65:3044\u20133048","journal-title":"Cancer Res"},{"key":"829_CR117","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, Krishnan I, Maroni G, Meyerovitz CV, Kerwin CM et al (2019) Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity 50:1317\u20131334.e1310","journal-title":"Immunity"}],"container-title":["The EMBO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00829-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44318-026-00829-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44318-026-00829-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:32:56Z","timestamp":1785738776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44318-026-00829-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":117,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2026,8,3]]}},"alternative-id":["829"],"URL":"https:\/\/doi.org\/10.1038\/s44318-026-00829-6","relation":{},"ISSN":["1460-2075"],"issn-type":[{"value":"1460-2075","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}